A five-year old British Columbia-based medical cannabis company just made its debut in the U.S. markets.

Tilray, which sell its products to patients, as well as researchers, governments, and pharmacies, opened on the NASDAQ on Thursday.

The company priced 9 million shares at $17 a share and they hit as high as $22.39. This represented an increase of 32%.

Tilray is the very first cannabis company to conduct an IPO in the United States. but cannot sell its products in the U.S. market, given that marijuana remains illegal under federal law.

So far 30 states and Washington, D.C. have legalized it in some form.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Jack in the Box is Celebrating Marijuana Becoming Legal in California
23 December 2017
This Town Has Just Voted to Ban Recreational Marijuana Shops
20 September 2017
Prosecutors in Indiana Write a Letter Against Marijuana
09 November 2017